Company
Biond Biologics
Innovative immunotherapies in Oncology
Also known as Biond Biologics Ltd.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Biond Biologics Ltd.
Record updated 28 September 2026
About
Biond Biologics is a private, clinical-stage biopharmaceutical company developing first-in-class immunotherapies for the treatment of cancer and immune-mediated diseases.
Funding snapshot
- Total raised
- $8MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $8M2026-06-01
Funding rounds
- Round, 2026
- $8M2026-06-01, Company stated
Products
- Other
- BND-22
- Other
- BND-35
- Other
- BND-67